Omeprazole 40 mg IV Dosing in a 13-Year-Old, 28 kg Patient
Yes, you can administer omeprazole 40 mg IV to this patient, as it falls within the appropriate weight-based dosing range for pediatric patients.
Dosing Rationale
Weight-Based Calculation
- This 28 kg patient requires approximately 0.7–3.3 mg/kg/day of omeprazole based on pediatric guidelines 1
- At 40 mg, this represents 1.43 mg/kg, which is well within the recommended range 1
- The FDA label confirms pharmacokinetic data support dosing in children >20 kg aged 6-16 years 2
Evidence Supporting This Dose
Pharmacokinetic studies demonstrate that:
- Children >20 kg (6-16 years) achieve similar AUC values to adults when given comparable mg/kg doses 2
- A 40 mg dose in this weight range produces appropriate drug exposure without excessive accumulation 2
- Research in critically ill children suggests 1 mg/kg twice daily (which would be 28 mg per dose for this patient) is effective, making a single 40 mg dose reasonable 3
For severe acid suppression needs:
- Studies in infants demonstrate that 40 mg/1.73 m² is required to maintain gastric pH >4 for >90% of monitored time 4
- This patient's body surface area would be approximately 1.0 m², making 40 mg an appropriate dose 4
- The 40 mg IV dose produces immediate maximal acid suppression, unlike lower doses that require several days to reach peak effect 5
Important Caveats
Infusion Preparation and Stability
- Prepare as 0.8 mg/mL concentration (40 mg in 50 mL normal saline) to minimize fluid load 6
- Change infusion every 12 hours due to significant degradation after this timepoint (concentration drops to 60% by 24 hours) 6
- Administer as 1-hour infusion for optimal pharmacokinetics 4
Monitoring Considerations
- Renal function monitoring is prudent with prolonged use, as real-world data show signals for acute kidney injury and chronic kidney disease with omeprazole 7
- Be aware of drug interactions, particularly if the patient is on CYP2C19 substrates or antiretrovirals 2
- Consider vitamin B12 status with chronic use, as omeprazole may impair absorption 8
Clinical Context
- The systemic clearance in children (0.23–0.68 L/kg/h) is similar to adults, supporting standard dosing approaches 3, 9
- High inter-individual variability exists (75% between-patient variability in clearance), so clinical response should guide ongoing therapy 3
- This dose is well-tolerated in pediatric populations across multiple studies 3, 4, 9
The 40 mg IV dose is appropriate for this 13-year-old, 28 kg patient and aligns with both FDA-approved pediatric dosing parameters and clinical research evidence.